{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T02:47:55Z","timestamp":1791686875362,"version":"4.3.4"},"reference-count":208,"publisher":"Springer Science and Business Media LLC","issue":"41","license":[{"start":{"date-parts":[[2016,2,29]],"date-time":"2016-02-29T00:00:00Z","timestamp":1456704000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,2,29]],"date-time":"2016-02-29T00:00:00Z","timestamp":1456704000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2016,10,13]]},"DOI":"10.1038\/onc.2016.34","type":"journal-article","created":{"date-parts":[[2016,2,29]],"date-time":"2016-02-29T11:02:37Z","timestamp":1456743757000},"page":"5337-5349","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":263,"title":["The tumor microenvironment in esophageal cancer"],"prefix":"10.1038","volume":"35","author":[{"given":"E W","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T A","family":"Karakasheva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P D","family":"Hicks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A J","family":"Bass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A K","family":"Rustgi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,2,29]]},"reference":[{"key":"BFonc201634_CR1","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/S0140-6736(12)60643-6","volume":"381","author":"A Pennathur","year":"2013","unstructured":"Pennathur A, Gibson MK, Jobe BA, Luketich JD . Oesophageal carcinoma. Lancet 2013; 381: 400\u2013412.","journal-title":"Lancet"},{"key":"BFonc201634_CR2","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1056\/NEJMra1314530","volume":"371","author":"AK Rustgi","year":"2014","unstructured":"Rustgi AK, El-Serag HB . Esophageal carcinoma. N Engl J Med 2014; 371: 2499\u20132509.","journal-title":"N Engl J Med"},{"key":"BFonc201634_CR3","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s00432-004-0610-7","volume":"131","author":"P Sunpaweravong","year":"2005","unstructured":"Sunpaweravong P, Sunpaweravong S, Puttawibul P, Mitarnun W, Zeng C, Bar\u00f3n AE et al. Epidermal growth factor receptor and cyclin D1 are independently amplified and overexpressed in esophageal squamous cell carcinoma. J Cancer Res Clin Oncol 2005; 131: 111\u2013119.","journal-title":"J Cancer Res Clin Oncol"},{"key":"BFonc201634_CR4","doi-asserted-by":"crossref","first-page":"9958","DOI":"10.1073\/pnas.87.24.9958","volume":"87","author":"MC Hollstein","year":"1990","unstructured":"Hollstein MC, Metcalf RA, Welsh JA, Montesano R, Harris CC . Frequent mutation of the p53 gene in human esophageal cancer. Proc Natl Acad Sci USA 1990; 87: 9958\u20139961.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc201634_CR5","doi-asserted-by":"crossref","first-page":"3260","DOI":"10.1245\/s10434-007-9511-8","volume":"14","author":"Y Chung","year":"2007","unstructured":"Chung Y, Lam AKY, Luk JM, Law S, Chan K-W, Lee P-Y et al. Altered E-cadherin expression and p120 catenin localization in esophageal squamous cell carcinoma. Ann Surg Oncol 2007; 14: 3260\u20133267.","journal-title":"Ann Surg Oncol"},{"key":"BFonc201634_CR6","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/nature13176","volume":"509","author":"Y Song","year":"2014","unstructured":"Song Y, Li L, Ou Y, Gao Z, Li E, Li X et al. Identification of genomic alterations in oesophageal squamous cell cancer. Nature 2014; 509: 91\u201395.","journal-title":"Nature"},{"key":"BFonc201634_CR7","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1038\/ng.3343","volume":"47","author":"MD Stachler","year":"2015","unstructured":"Stachler MD, Taylor-Weiner A, Peng S, McKenna A, Agoston AT, Odze RD et al. Paired exome analysis of Barrett\u2019s esophagus and adenocarcinoma. Nat Genet 2015; 47: 1047\u20131055.","journal-title":"Nat Genet"},{"key":"BFonc201634_CR8","doi-asserted-by":"crossref","first-page":"5904","DOI":"10.1038\/onc.2008.271","volume":"27","author":"TL Whiteside","year":"2008","unstructured":"Whiteside TL . The tumor microenvironment and its role in promoting tumor growth. Oncogene 2008; 27: 5904\u20135912.","journal-title":"Oncogene"},{"key":"BFonc201634_CR9","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/nature01322","volume":"420","author":"LM Coussens","year":"2002","unstructured":"Coussens LM, Werb Z . Inflammation and cancer. Nature 2002; 420: 860\u2013867.","journal-title":"Nature"},{"key":"BFonc201634_CR10","first-page":"419","volume":"134","author":"EW Gillison","year":"1972","unstructured":"Gillison EW, De Castro VA, Nyhus LM, Kusakari K, Bombeck CT . The significance of bile in reflux esophagitis. Surg Gynecol Obstet 1972; 134: 419\u2013424.","journal-title":"Surg Gynecol Obstet"},{"key":"BFonc201634_CR11","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/00000658-199522240-00010","volume":"222","author":"WK Kauer","year":"1995","unstructured":"Kauer WK, Peters JH, DeMeester TR, Ireland AP, Bremner CG, Hagen JA . Mixed reflux of gastric and duodenal juices is more harmful to the esophagus than gastric juice alone. The need for surgical therapy re-emphasized. Ann Surg 1995; 222: 525\u2013531 discussion 531\u20133.","journal-title":"Ann Surg"},{"key":"BFonc201634_CR12","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1136\/gut.2006.103697","volume":"56","author":"K Dvorak","year":"2007","unstructured":"Dvorak K, Payne CM, Chavarria M, Ramsey L, Dvorakova B, Bernstein H et al. Bile acids in combination with low pH induce oxidative stress and oxidative DNA damage: relevance to the pathogenesis of Barrett\u2019s oesophagus. Gut 2007; 56: 763\u2013771.","journal-title":"Gut"},{"key":"BFonc201634_CR13","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1136\/gut.2007.121244","volume":"56","author":"S Song","year":"2007","unstructured":"Song S, Guha S, Liu K, Buttar NS, Bresalier RS . COX-2 induction by unconjugated bile acids involves reactive oxygen species-mediated signalling pathways in Barrett\u2019s oesophagus and oesophageal adenocarcinoma. Gut 2007; 56: 1512\u20131521.","journal-title":"Gut"},{"key":"BFonc201634_CR14","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1053\/j.gastro.2010.01.048","volume":"138","author":"DH Wang","year":"2010","unstructured":"Wang DH, Clemons NJ, Miyashita T, Dupuy AJ, Zhang W, Szczepny A et al. Aberrant epithelial-mesenchymal Hedgehog signaling characterizes Barrett\u2019s metaplasia. Gastroenterology 2010; 138: 1810\u20131822.","journal-title":"Gastroenterology"},{"key":"BFonc201634_CR15","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ccr.2011.12.004","volume":"21","author":"M Quante","year":"2012","unstructured":"Quante M, Bhagat G, Abrams JA, Marache F, Good P, Lee MD et al. Bile acid and inflammation activate gastric cardia stem cells in a mouse model of barrett-like metaplasia. Cancer Cell 2012; 21: 36\u201351.","journal-title":"Cancer Cell"},{"key":"BFonc201634_CR16","first-page":"9","volume":"7","author":"HE Poulsen","year":"1998","unstructured":"Poulsen HE, Prieme H, Loft S . Role of oxidative DNA damage in cancer initiation and promotion. Eur J Cancer Prev 1998; 7: 9\u201316.","journal-title":"Eur J Cancer Prev"},{"key":"BFonc201634_CR17","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1572-0241.2002.05444.x","volume":"97","author":"A Farhadi","year":"2002","unstructured":"Farhadi A, Fields J, Banan A, Keshavarzian A . Reactive oxygen species: are they involved in the pathogenesis of GERD, Barrett\u2019s esophagus, and the latter's progression toward esophageal cancer? Am J Gastroenterol 2002; 97: 22\u201326.","journal-title":"Am J Gastroenterol"},{"key":"BFonc201634_CR18","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1177\/0192623309356453","volume":"38","author":"JE Klaunig","year":"2010","unstructured":"Klaunig JE, Kamendulis LM, Hocevar BA . Oxidative stress and oxidative damage in carcinogenesis. Toxicol Pathol 2010; 38: 96\u2013109.","journal-title":"Toxicol Pathol"},{"key":"BFonc201634_CR19","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1002\/ijc.10755","volume":"102","author":"EIT Sihvo","year":"2002","unstructured":"Sihvo EIT, Salminen JT, Rantanen TK, R\u00e4m\u00f6 OJ, Ahotupa M, F\u00e4rkkil\u00e4 M et al. Oxidative stress has a role in malignant transformation in Barrett\u2019s oesophagus. Int J Cancer 2002; 102: 551\u2013555.","journal-title":"Int J Cancer"},{"key":"BFonc201634_CR20","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0027-5107(01)00199-3","volume":"480-481","author":"JS Lee","year":"2001","unstructured":"Lee JS, Oh TY, Ahn BO, Cho H, Kim WB, Kim YB et al. Involvement of oxidative stress in experimentally induced reflux esophagitis and Barrett\u2019s esophagus: clue for the chemoprevention of esophageal carcinoma by antioxidants. Mutat Res Mol Mech Mutagen 2001; 480-481: 189\u2013200.","journal-title":"Mutat Res Mol Mech Mutagen"},{"key":"BFonc201634_CR21","doi-asserted-by":"crossref","first-page":"5176","DOI":"10.1158\/1078-0432.CCR-07-1152","volume":"13","author":"RCG Martin","year":"2007","unstructured":"Martin RCG, Liu Q, Wo JM, Ray MB, Li Y . Chemoprevention of carcinogenic progression to esophageal adenocarcinoma by the manganese superoxide dismutase supplementation. Clin Cancer Res 2007; 13: 5176\u20135182.","journal-title":"Clin Cancer Res"},{"key":"BFonc201634_CR22","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S1470-2045(02)00849-5","volume":"3","author":"F Bianchini","year":"2002","unstructured":"Bianchini F, Kaaks R, Vainio H . Overweight, obesity, and cancer risk. Lancet Oncol 2002; 3: 565\u2013574.","journal-title":"Lancet Oncol"},{"key":"BFonc201634_CR23","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.diabres.2004.11.007","volume":"69","author":"HS Park","year":"2005","unstructured":"Park HS, Park JY, Yu R . Relationship of obesity and visceral adiposity with serum concentrations of CRP, TNF-alpha and IL-6. Diabetes Res Clin Pract 2005; 69: 29\u201335.","journal-title":"Diabetes Res Clin Pract"},{"key":"BFonc201634_CR24","doi-asserted-by":"crossref","first-page":"6071","DOI":"10.1038\/sj.onc.1205731","volume":"21","author":"C Tselepis","year":"2002","unstructured":"Tselepis C, Perry I, Dawson C, Hardy R, Darnton SJ, McConkey C et al. Tumour necrosis factor-alpha in Barrett\u2019s oesophagus: a potential novel mechanism of action. Oncogene 2002; 21: 6071\u20136081.","journal-title":"Oncogene"},{"key":"BFonc201634_CR25","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1089\/jir.1996.16.1001","volume":"16","author":"M Oka","year":"1996","unstructured":"Oka M, Iizuka N, Yamamoto K, Gondo T, Abe T, Hazama S et al. The influence of interleukin-6 on the growth of human esophageal cancer cell lines. J Interferon Cytokine Res 1996; 16: 1001\u20131006.","journal-title":"J Interferon Cytokine Res"},{"key":"BFonc201634_CR26","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/nrgastro.2011.23","volume":"8","author":"P Kant","year":"2011","unstructured":"Kant P, Hull MA . Excess body weight and obesity\u2014the link with gastrointestinal and hepatobiliary cancer. Nat Rev Gastroenterol Hepatol 2011; 8: 224\u2013238.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"BFonc201634_CR27","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.cgh.2013.02.017","volume":"11","author":"C Duggan","year":"2013","unstructured":"Duggan C, Onstad L, Hardikar S, Blount PL, Reid BJ, Vaughan TL . Association between markers of obesity and progression from Barrett\u2019s esophagus to esophageal adenocarcinoma. Clin Gastroenterol Hepatol 2013; 11: 934\u2013943.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"BFonc201634_CR28","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/bjs.7072","volume":"97","author":"JM Howard","year":"2010","unstructured":"Howard JM, Beddy P, Ennis D, Keogan M, Pidgeon GP, Reynolds J V . Associations between leptin and adiponectin receptor upregulation, visceral obesity and tumour stage in oesophageal and junctional adenocarcinoma. Br J Surg 2010; 97: 1020\u20131027.","journal-title":"Br J Surg"},{"key":"BFonc201634_CR29","doi-asserted-by":"crossref","first-page":"4505","DOI":"10.1210\/en.2006-0224","volume":"147","author":"O Ogunwobi","year":"2006","unstructured":"Ogunwobi O, Mutungi G, Beales ILP . Leptin stimulates proliferation and inhibits apoptosis in Barrett\u2019s esophageal adenocarcinoma cells by cyclooxygenase-2-dependent, prostaglandin-E2-mediated transactivation of the epidermal growth factor receptor and c-Jun NH2-terminal kinase activation. Endocrinology 2006; 147: 4505\u20134516.","journal-title":"Endocrinology"},{"key":"BFonc201634_CR30","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1136\/gut.2008.171553","volume":"58","author":"JH Rubenstein","year":"2009","unstructured":"Rubenstein JH, Kao JY, Madanick RD, Zhang M, Wang M, Spacek MB et al. Association of adiponectin multimers with Barrett\u2019s oesophagus. Gut 2009; 58: 1583\u20131589.","journal-title":"Gut"},{"key":"BFonc201634_CR31","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1186\/s12885-015-1379-6","volume":"15","author":"X Wei","year":"2015","unstructured":"Wei X, Wang F, Zhang D, Qiu M, Ren C, Jin Y et al. A novel inflammation-based prognostic score in esophageal squamous cell carcinoma: the C-reactive protein\/albumin ratio. BMC Cancer 2015; 15: 350.","journal-title":"BMC Cancer"},{"key":"BFonc201634_CR32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5301\/JBM.2011.8737","volume":"27","author":"J Radojicic","year":"2012","unstructured":"Radojicic J, Zaravinos A, Spandidos DA . HPV, KRAS mutations, alcohol consumption and tobacco smoking effects on esophageal squamous-cell carcinoma carcinogenesis. Int J Biol Markers 2012; 27: 1\u201312.","journal-title":"Int J Biol Markers"},{"key":"BFonc201634_CR33","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/dote.12107","volume":"27","author":"N Kubo","year":"2014","unstructured":"Kubo N, Morita M, Nakashima Y, Kitao H, Egashira A, Saeki H et al. Oxidative DNA damage in human esophageal cancer: clinicopathological analysis of 8-hydroxydeoxyguanosine and its repair enzyme. Dis Esophagus 2014; 27: 285\u2013293.","journal-title":"Dis Esophagus"},{"key":"BFonc201634_CR34","first-page":"9250","volume":"105","author":"N Shivappa","year":"2015","unstructured":"Shivappa N, Zucchetto A, Serraino D, Rossi M, La Vecchia C, H\u00e9bert JR . Dietary inflammatory index and risk of esophageal squamous cell cancer in a case-control study from Italy. Cancer Causes Control 2015; 105: 9250\u20139255.","journal-title":"Cancer Causes Control"},{"key":"BFonc201634_CR35","doi-asserted-by":"crossref","first-page":"4550","DOI":"10.1038\/onc.2011.592","volume":"31","author":"C Taccioli","year":"2012","unstructured":"Taccioli C, Chen H, Jiang Y, Liu XP, Huang K, Smalley KJ et al. Dietary zinc deficiency fuels esophageal cancer development by inducing a distinct inflammatory signature. Oncogene 2012; 31: 4550\u20134558.","journal-title":"Oncogene"},{"key":"BFonc201634_CR36","unstructured":"Goldman L, Schafer AI Goldman-Cecil Medicine: Expert Consult - Online. Elsevier Health Sciences, 2015 https:\/\/books.google.com\/books?id=40Z9CAAAQBAJ&pgis=1 (accessed 4 August 2015)."},{"key":"BFonc201634_CR37","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1053\/j.gastro.2009.04.046","volume":"137","author":"L Yang","year":"2009","unstructured":"Yang L, Lu X, Nossa CW, Francois F, Peek RM, Pei Z . Inflammation and intestinal metaplasia of the distal esophagus are associated with alterations in the microbiome. Gastroenterology 2009; 137: 588\u2013597.","journal-title":"Gastroenterology"},{"key":"BFonc201634_CR38","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1111\/apt.12666","volume":"39","author":"MM Walker","year":"2014","unstructured":"Walker MM, Talley NJ . Review article: bacteria and pathogenesis of disease in the upper gastrointestinal tract\u2014beyond the era of Helicobacter pylori. Aliment Pharmacol Ther 2014; 39: 767\u2013779.","journal-title":"Aliment Pharmacol Ther"},{"key":"BFonc201634_CR39","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1158\/1078-0432.CCR-11-0934","volume":"18","author":"L Yang","year":"2012","unstructured":"Yang L, Francois F, Pei Z . Molecular pathways: pathogenesis and clinical implications of microbiome alteration in esophagitis and Barrett esophagus. Clin Cancer Res 2012; 18: 2138\u20132144.","journal-title":"Clin Cancer Res"},{"key":"BFonc201634_CR40","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1086\/518578","volume":"45","author":"S Macfarlane","year":"2007","unstructured":"Macfarlane S, Furrie E, Macfarlane GT, Dillon JF . Microbial colonization of the upper gastrointestinal tract in patients with Barrett\u2019s esophagus. Clin Infect Dis 2007; 45: 29\u201338.","journal-title":"Clin Infect Dis"},{"key":"BFonc201634_CR41","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.cgh.2013.08.029","volume":"12","author":"JH Rubenstein","year":"2014","unstructured":"Rubenstein JH, Inadomi JM, Scheiman J, Schoenfeld P, Appelman H, Zhang M et al. Association between Helicobacter pylori and Barrett\u2019s esophagus, erosive esophagitis, and gastroesophageal reflux symptoms. Clin Gastroenterol Hepatol 2014; 12: 239\u2013245.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"BFonc201634_CR42","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.coph.2009.06.010","volume":"9","author":"MMM Abdel-Latif","year":"2009","unstructured":"Abdel-Latif MMM, Duggan S, Reynolds JV, Kelleher D . Inflammation and esophageal carcinogenesis. Curr Opin Pharmacol 2009; 9: 396\u2013404.","journal-title":"Curr Opin Pharmacol"},{"key":"BFonc201634_CR43","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1038\/nrc3818","volume":"14","author":"H Yu","year":"2014","unstructured":"Yu H, Lee H, Herrmann A, Buettner R, Jove R . Revisiting STAT3 signalling in cancer: new and unexpected biological functions. Nat Rev Cancer 2014; 14: 736\u2013746.","journal-title":"Nat Rev Cancer"},{"key":"BFonc201634_CR44","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1016\/j.cca.2012.05.009","volume":"413","author":"M Groblewska","year":"2012","unstructured":"Groblewska M, Mroczko B, Sosnowska D, Szmitkowski M . Interleukin 6 and C-reactive protein in esophageal cancer. Clin Chim Acta 2012; 413: 1583\u20131590.","journal-title":"Clin Chim Acta"},{"key":"BFonc201634_CR45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/bj20030407","volume":"374","author":"PC Heinrich","year":"2003","unstructured":"Heinrich PC, Behrmann I, Haan S, Hermanns HM, M\u00fcller-Newen G, Schaper F . Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochem J 2003; 374: 1\u201320.","journal-title":"Biochem J"},{"key":"BFonc201634_CR46","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1016\/j.ejca.2005.08.016","volume":"41","author":"DR Hodge","year":"2005","unstructured":"Hodge DR, Hurt EM, Farrar WL . The role of IL-6 and STAT3 in inflammation and cancer. Eur J Cancer 2005; 41: 2502\u20132512.","journal-title":"Eur J Cancer"},{"key":"BFonc201634_CR47","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/nm976","volume":"10","author":"T Wang","year":"2004","unstructured":"Wang T, Niu G, Kortylewski M, Burdelya L, Shain K, Zhang S et al. Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells. Nat Med 2004; 10: 48\u201354.","journal-title":"Nat Med"},{"key":"BFonc201634_CR48","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1158\/1078-0432.CCR-0437-03","volume":"10","author":"K Dvorakova","year":"2004","unstructured":"Dvorakova K . Increased expression and secretion of interleukin-6 in patients with Barrett\u2019s esophagus. Clin Cancer Res 2004; 10: 2020\u20132028.","journal-title":"Clin Cancer Res"},{"key":"BFonc201634_CR49","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.3748\/wjg.v19.i15.2307","volume":"19","author":"K Dvorak","year":"2013","unstructured":"Dvorak K, Dvorak B . Role of interleukin-6 in Barrett\u2019s esophagus pathogenesis. World J Gastroenterol 2013; 19: 2307\u20132312.","journal-title":"World J Gastroenterol"},{"key":"BFonc201634_CR50","doi-asserted-by":"crossref","first-page":"G454","DOI":"10.1152\/ajpgi.00458.2010","volume":"300","author":"HY Zhang","year":"2011","unstructured":"Zhang HY, Zhang Q, Zhang X, Yu C, Huo X, Cheng E et al. Cancer-related inflammation and Barrett\u2019s carcinogenesis: interleukin-6 and STAT3 mediate apoptotic resistance in transformed Barrett's cells. Am J Physiol Gastrointest Liver Physiol 2011; 300: G454\u2013G460.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"BFonc201634_CR51","doi-asserted-by":"crossref","first-page":"5305","DOI":"10.1158\/1078-0432.CCR-07-0483","volume":"13","author":"K Dvorak","year":"2007","unstructured":"Dvorak K, Chavarria M, Payne CM, Ramsey L, Crowley-Weber C, Dvorakova B et al. Activation of the interleukin-6\/STAT3 antiapoptotic pathway in esophageal cells by bile acids and low pH: relevance to Barrett\u2019s esophagus. Clin Cancer Res 2007; 13: 5305\u20135313.","journal-title":"Clin Cancer Res"},{"key":"BFonc201634_CR52","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/j.1442-2050.2011.01242.x","volume":"25","author":"M \u0141ukaszewicz-Zaj\u0105c","year":"2012","unstructured":"\u0141ukaszewicz-Zaj\u0105c M, Mroczko B, Koz\u0142owski M, Nikli\u0144ski J, Lauda\u0144ski J, Szmitkowski M . Higher importance of interleukin 6 than classic tumor markers (carcinoembryonic antigen and squamous cell cancer antigen) in the diagnosis of esophageal cancer patients. Dis Esophagus 2012; 25: 242\u2013249.","journal-title":"Dis Esophagus"},{"key":"BFonc201634_CR53","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1158\/1055-9965.EPI-14-0384","volume":"23","author":"S Hardikar","year":"2014","unstructured":"Hardikar S, Onstad L, Song X, Wilson AM, Montine TJ, Kratz M et al. Inflammation and oxidative stress markers and esophageal adenocarcinoma incidence in a Barrett\u2019s esophagus cohort. Cancer Epidemiol Biomarkers Prev 2014; 23: 2393\u20132403.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"BFonc201634_CR54","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s00011-009-0060-4","volume":"58","author":"K Eder","year":"2009","unstructured":"Eder K, Baffy N, Falus A, Fulop AK . The major inflammatory mediator interleukin-6 and obesity. Inflamm Res 2009; 58: 727\u2013736.","journal-title":"Inflamm Res"},{"key":"BFonc201634_CR55","doi-asserted-by":"crossref","first-page":"7809","DOI":"10.1038\/sj.onc.1207084","volume":"22","author":"C-M Leu","year":"2003","unstructured":"Leu C-M, Wong F-H, Chang C, Huang S-F, Hu C . Interleukin-6 acts as an antiapoptotic factor in human esophageal carcinoma cells through the activation of both STAT3 and mitogen-activated protein kinase pathways. Oncogene 2003; 22: 7809\u20137818.","journal-title":"Oncogene"},{"key":"BFonc201634_CR56","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.canlet.2008.05.035","volume":"271","author":"S Yan","year":"2008","unstructured":"Yan S, Zhou C, Zhang W, Zhang G, Zhao X, Yang S et al. Beta-catenin\/TCF pathway upregulates STAT3 expression in human esophageal squamous cell carcinoma. Cancer Lett 2008; 271: 85\u201397.","journal-title":"Cancer Lett"},{"key":"BFonc201634_CR57","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1111\/cas.12187","volume":"104","author":"Y Makuuchi","year":"2013","unstructured":"Makuuchi Y, Honda K, Osaka Y, Kato K, Kojima T, Daiko H et al. Soluble interleukin-6 receptor is a serum biomarker for the response of esophageal carcinoma to neoadjuvant chemoradiotherapy. Cancer Sci 2013; 104: 1045\u20131051.","journal-title":"Cancer Sci"},{"key":"BFonc201634_CR58","first-page":"2699","volume":"33","author":"M Yoneda","year":"2013","unstructured":"Yoneda M, Fujiwara H, Furutani A, Ikai A, Tada H, Shiozaki A et al. Prognostic impact of tumor IL-6 expression after preoperative chemoradiotherapy in patients with advanced esophageal squamous cell carcinoma. Anticancer Res 2013; 33: 2699\u20132705.","journal-title":"Anticancer Res"},{"key":"BFonc201634_CR59","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1476-4598-12-26","volume":"12","author":"M-F Chen","year":"2013","unstructured":"Chen M-F, Chen P-T, Lu MS, Lin PY, Chen W-C, Lee K-D . IL-6 expression predicts treatment response and outcome in squamous cell carcinoma of the esophagus. Mol Cancer 2013; 12: 26.","journal-title":"Mol Cancer"},{"key":"BFonc201634_CR60","doi-asserted-by":"crossref","first-page":"8716","DOI":"10.18632\/oncotarget.2368","volume":"5","author":"M-F Chen","year":"2014","unstructured":"Chen M-F, Kuan F-C, Yen T-C, Lu M-S, Lin P-Y, Chung Y-H et al. IL-6-stimulated CD11b+CD14+HLA-DR \u2212 myeloid-derived suppressor cells, are associated with progression and poor prognosis in squamous cell carcinoma of the esophagus. Oncotarget 2014; 5: 8716\u20138728.","journal-title":"Oncotarget"},{"key":"BFonc201634_CR61","first-page":"7989","volume":"7","author":"H Li","year":"2014","unstructured":"Li H, Xiao W, Ma J, Zhang Y, Li R, Ye J et al. Dual high expression of STAT3 and cyclinD1 is associated with poor prognosis after curative resection of esophageal squamous cell carcinoma. Int J Clin Exp Pathol 2014; 7: 7989\u20137998.","journal-title":"Int J Clin Exp Pathol"},{"key":"BFonc201634_CR62","doi-asserted-by":"crossref","first-page":"4074","DOI":"10.1158\/0008-5472.CAN-14-3639","volume":"75","author":"TA Karakasheva","year":"2015","unstructured":"Karakasheva TA, Waldron TJ, Eruslanov E, Lee J-S, O\u2019Brien S, Hicks PD et al. CD38-expressing myeloid-derived suppressor cells promote tumor growth in a murine model of esophageal cancer. Cancer Res 2015; 75: 4074\u20134085.","journal-title":"Cancer Res"},{"key":"BFonc201634_CR63","first-page":"67","volume":"31","author":"K Suchi","year":"2011","unstructured":"Suchi K, Fujiwara H, Okamura S, Okamura H, Umehara S, Todo M et al. Overexpression of interleukin-6 suppresses cisplatin-induced cytotoxicity in esophageal squamous cell carcinoma cells. Anticancer Res 2011; 31: 67\u201375.","journal-title":"Anticancer Res"},{"key":"BFonc201634_CR64","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1007\/s13277-014-2823-y","volume":"36","author":"Q Zhang","year":"2015","unstructured":"Zhang Q, Zhang C, He J, Guo Q, Hu D, Yang X et al. STAT3 inhibitor stattic enhances radiosensitivity in esophageal squamous cell carcinoma. Tumour Biol 2015; 36: 2135\u20132142.","journal-title":"Tumour Biol"},{"key":"BFonc201634_CR65","doi-asserted-by":"crossref","first-page":"G561","DOI":"10.1152\/ajpgi.00033.2012","volume":"303","author":"C Yu","year":"2012","unstructured":"Yu C, Zhang Q, Zhang HY, Zhang X, Huo X, Cheng E et al. Targeting the intrinsic inflammatory pathway: honokiol exerts proapoptotic effects through STAT3 inhibition in transformed Barrett\u2019s cells. Am J Physiol Gastrointest Liver Physiol 2012; 303: G561\u2013G569.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"BFonc201634_CR66","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1007\/s13277-014-2823-y","volume":"36","author":"Q Zhang","year":"2014","unstructured":"Zhang Q, Zhang C, He J, Guo Q, Hu D, Yang X et al. STAT3 inhibitor stattic enhances radiosensitivity in esophageal squamous cell carcinoma. Tumour Biol 2014; 36: 2135\u20132142.","journal-title":"Tumour Biol"},{"key":"BFonc201634_CR67","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1146\/annurev.iy.12.040194.001041","volume":"12","author":"PA Baeuerle","year":"1994","unstructured":"Baeuerle PA, Henkel T . Function and activation of NF-kappa B in the immune system. Annu Rev Immunol 1994; 12: 141\u2013179.","journal-title":"Annu Rev Immunol"},{"key":"BFonc201634_CR68","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/nrc780","volume":"2","author":"M Karin","year":"2002","unstructured":"Karin M, Cao Y, Greten FR, Li Z-W . NF-kappaB in cancer: from innocent bystander to major culprit. Nat Rev Cancer 2002; 2: 301\u2013310.","journal-title":"Nat Rev Cancer"},{"key":"BFonc201634_CR69","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1158\/1535-7163.MCT-06-0351","volume":"5","author":"JG Izzo","year":"2006","unstructured":"Izzo JG, Correa AM, Wu T-T, Malhotra U, Chao CKS, Luthra R et al. Pretherapy nuclear factor-kappaB status, chemoradiation resistance, and metastatic progression in esophageal carcinoma. Mol Cancer Ther 2006; 5: 2844\u20132850.","journal-title":"Mol Cancer Ther"},{"key":"BFonc201634_CR70","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1097\/01.sla.0000118751.95179.c6","volume":"239","author":"MMM Abdel-Latif","year":"2004","unstructured":"Abdel-Latif MMM, O\u2019Riordan J, Windle HJ, Carton E, Ravi N, Kelleher D et al. NF-kappaB activation in esophageal adenocarcinoma: relationship to Barrett\u2019s metaplasia, survival, and response to neoadjuvant chemoradiotherapy. Ann Surg 2004; 239: 491\u2013500.","journal-title":"Ann Surg"},{"key":"BFonc201634_CR71","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1093\/carcin\/bgh032","volume":"25","author":"GJS Jenkins","year":"2004","unstructured":"Jenkins GJS, Harries K, Doak SH, Wilmes A, Griffiths AP, Baxter JN et al. The bile acid deoxycholic acid (DCA) at neutral pH activates NF-kappaB and induces IL-8 expression in oesophageal cells in vitro. Carcinogenesis 2004; 25: 317\u2013323.","journal-title":"Carcinogenesis"},{"key":"BFonc201634_CR72","first-page":"548","volume":"65","author":"U Malhotra","year":"2005","unstructured":"Malhotra U, Hittelman WN, Wu TT, Luthra R, Swisher S, Luthra M et al. Association of activated NF-kB, altered cyclin D1 and poor outcome in esophageal adenocarcinoma. Cancer Res 2005; 65: 548.","journal-title":"Cancer Res"},{"key":"BFonc201634_CR73","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1111\/j.1572-0241.2005.41338.x","volume":"100","author":"JM O\u2019Riordan","year":"2005","unstructured":"O\u2019Riordan JM, Abdel-latif MM, Ravi N, McNamara D, Byrne PJ, McDonald GSA et al. Proinflammatory cytokine and nuclear factor kappa-B expression along the inflammation-metaplasia-dysplasia-adenocarcinoma sequence in the esophagus. Am J Gastroenterol 2005; 100: 1257\u20131264.","journal-title":"Am J Gastroenterol"},{"key":"BFonc201634_CR74","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1158\/1055-9965.EPI-06-1083","volume":"16","author":"JG Izzo","year":"2007","unstructured":"Izzo JG, Malhotra U, Wu T-T, Luthra R, Correa AM, Swisher SG et al. Clinical biology of esophageal adenocarcinoma after surgery is influenced by nuclear factor-kappaB expression. Cancer Epidemiol Biomarkers Prev 2007; 16: 1200\u20131205.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"BFonc201634_CR75","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.ccr.2011.02.007","volume":"19","author":"DB Stairs","year":"2011","unstructured":"Stairs DB, Bayne LJ, Rhoades B, Vega ME, Waldron TJ, Kalabis J et al. Deletion of p120-catenin results in a tumor microenvironment with inflammation and cancer that establishes it as a tumor suppressor gene. Cancer Cell 2011; 19: 470\u2013483.","journal-title":"Cancer Cell"},{"key":"BFonc201634_CR76","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1093\/carcin\/bgm152","volume":"28","author":"B Li","year":"2007","unstructured":"Li B, Cheung PY, Wang X, Tsao SW, Ling MT, Wong YC et al. Id-1 activation of PI3K\/Akt\/NF??B signaling pathway and its significance in promoting survival of esophageal cancer cells. Carcinogenesis 2007; 28: 2313\u20132320.","journal-title":"Carcinogenesis"},{"key":"BFonc201634_CR77","doi-asserted-by":"crossref","first-page":"3638","DOI":"10.1158\/0008-5472.CAN-12-4028","volume":"73","author":"C Lin","year":"2013","unstructured":"Lin C, Song L, Gong H, Liu A, Lin X, Wu J et al. Nkx2-8 downregulation promotes angiogenesis and activates NF-\u03baB in esophageal cancer. Cancer Res 2013; 73: 3638\u20133648.","journal-title":"Cancer Res"},{"key":"BFonc201634_CR78","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1111\/j.1442-2050.2011.01308.x","volume":"25","author":"T Hatata","year":"2012","unstructured":"Hatata T, Higaki K, Tatebe S, Shomori K, Ikeguchi M . Immunohistochemical study of nuclear factor-\u03baB expression in esophageal squamous cell carcinoma: prognostic significance and sensitivity to treatment with 5-FU. Dis Esophagus 2012; 25: 716\u2013722.","journal-title":"Dis Esophagus"},{"key":"BFonc201634_CR79","doi-asserted-by":"crossref","first-page":"6735","DOI":"10.1158\/1078-0432.CCR-07-4843","volume":"14","author":"DJJ Waugh","year":"2008","unstructured":"Waugh DJJ, Wilson C . The interleukin-8 pathway in cancer. Clin Cancer Res 2008; 14: 6735\u20136741.","journal-title":"Clin Cancer Res"},{"key":"BFonc201634_CR80","doi-asserted-by":"crossref","first-page":"5911","DOI":"10.1038\/srep05911","volume":"4","author":"L Chen","year":"2014","unstructured":"Chen L, Fan J, Chen H, Meng Z, Chen Z, Wang P et al. The IL-8\/CXCR1 axis is associated with cancer stem cell-like properties and correlates with clinical prognosis in human pancreatic cancer cases. Sci Rep 2014; 4: 5911.","journal-title":"Sci Rep"},{"key":"BFonc201634_CR81","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s10555-006-9004-4","volume":"25","author":"RN Apte","year":"2006","unstructured":"Apte RN, Dotan S, Elkabets M, White MR, Reich E, Carmi Y et al. The involvement of IL-1 in tumorigenesis, tumor invasiveness, metastasis and tumor-host interactions. Cancer Metastasis Rev 2006; 25: 387\u2013408.","journal-title":"Cancer Metastasis Rev"},{"key":"BFonc201634_CR82","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/1476-4598-11-87","volume":"11","author":"Y Li","year":"2012","unstructured":"Li Y, Wang L, Pappan L, Galliher-Beckley A, Shi J . IL-1\u03b2 promotes stemness and invasiveness of colon cancer cells through Zeb1 activation. Mol Cancer 2012; 11: 87.","journal-title":"Mol Cancer"},{"key":"BFonc201634_CR83","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1001\/archsurg.142.6.554","volume":"142","author":"DS Oh","year":"2007","unstructured":"Oh DS, DeMeester SR, Vallbohmer D, Mori R, Kuramochi H, Hagen JA et al. Reduction of interleukin 8 gene expression in reflux esophagitis and Barrett\u2019s esophagus with antireflux surgery. Arch Surg 2007; 142: 554\u2013559 discussion 559\u2013560.","journal-title":"Arch Surg"},{"key":"BFonc201634_CR84","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1136\/gut.51.3.316","volume":"51","author":"RC Fitzgerald","year":"2002","unstructured":"Fitzgerald RC, Abdalla S, Onwuegbusi BA, Sirieix P, Saeed IT, Burnham WR et al. Inflammatory gradient in Barrett\u2019s oesophagus: implications for disease complications. Gut 2002; 51: 316\u2013322.","journal-title":"Gut"},{"key":"BFonc201634_CR85","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.surg.2013.06.013","volume":"154","author":"M Ogura","year":"2013","unstructured":"Ogura M, Takeuchi H, Kawakubo H, Nishi T, Fukuda K, Nakamura R et al. Clinical significance of CXCL-8\/CXCR-2 network in esophageal squamous cell carcinoma. Surgery 2013; 154: 512\u2013520.","journal-title":"Surgery"},{"key":"BFonc201634_CR86","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.jtcvs.2003.09.033","volume":"127","author":"DM Nguyen","year":"2004","unstructured":"Nguyen DM, Chen GA, Reddy R, Tsai W, Schrump WD, Cole G et al. Potentiation of paclitaxel cytotoxicity in lung and esophageal cancer cells by pharmacologic inhibition of the phosphoinositide 3-kinase\/protein kinase B (Akt)-mediated signaling pathway. J Thorac Cardiovasc Surg 2004; 127: 365\u2013375.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"BFonc201634_CR87","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/j.1745-7270.2006.00166.x","volume":"38","author":"F Tian","year":"2006","unstructured":"Tian F, Zang W-D, Hou W-H, Liu H-T, Xue L-X . Nuclear factor-kB signaling pathway constitutively activated in esophageal squamous cell carcinoma cell lines and inhibition of growth of cells by small interfering RNA. Acta Biochim Biophys Sin (Shanghai) 2006; 38: 318\u2013326.","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"BFonc201634_CR88","doi-asserted-by":"crossref","first-page":"G388","DOI":"10.1152\/ajpgi.90428.2008","volume":"296","author":"P Rafiee","year":"2009","unstructured":"Rafiee P, Nelson VM, Manley S, Wellner M, Floer M, Binion DG et al. Effect of curcumin on acidic pH-induced expression of IL-6 and IL-8 in human esophageal epithelial cells (HET-1A): role of PKC, MAPKs, and NF-kappaB. Am J Physiol Gastrointest Liver Physiol 2009; 296: G388\u2013G398.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"BFonc201634_CR89","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00535-011-0523-6","volume":"47","author":"H Oshima","year":"2012","unstructured":"Oshima H, Oshima M . The inflammatory network in the gastrointestinal tumor microenvironment: lessons from mouse models. J Gastroenterol 2012; 47: 97\u2013106.","journal-title":"J Gastroenterol"},{"key":"BFonc201634_CR90","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0016-5085(00)70254-X","volume":"118","author":"VN Shirvani","year":"2000","unstructured":"Shirvani VN, Ouatu-Lascar R, Kaur BS, Omary MB, Triadafilopoulos G . Cyclooxygenase 2 expression in Barrett\u2019s esophagus and adenocarcinoma: ex vivo induction by bile salts and acid exposure. Gastroenterology 2000; 118: 487\u2013496.","journal-title":"Gastroenterology"},{"key":"BFonc201634_CR91","first-page":"990","volume":"96","author":"CD Morris","year":"2001","unstructured":"Morris CD, Armstrong GR, Bigley G, Green H, Attwood SE . Cyclooxygenase-2 expression in the Barrett\u2019s metaplasia-dysplasia-adenocarcinoma sequence. Am J Gastroenterol 2001; 96: 990\u2013996.","journal-title":"Am J Gastroenterol"},{"key":"BFonc201634_CR92","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1093\/carcin\/bgi304","volume":"27","author":"H Zhi","year":"2006","unstructured":"Zhi H, Wang L, Zhang J, Zhou C, Ding F, Luo A et al. Significance of COX-2 expression in human esophageal squamous cell carcinoma. Carcinogenesis 2006; 27: 1214\u20131221.","journal-title":"Carcinogenesis"},{"key":"BFonc201634_CR93","doi-asserted-by":"crossref","first-page":"2946","DOI":"10.1245\/s10434-011-1645-z","volume":"18","author":"Y Akutsu","year":"2011","unstructured":"Akutsu Y, Hanari N, Yusup G, Komatsu-Akimoto A, Ikeda N, Mori M et al. COX2 expression predicts resistance to chemoradiotherapy in esophageal squamous cell carcinoma. Ann Surg Oncol 2011; 18: 2946\u20132951.","journal-title":"Ann Surg Oncol"},{"key":"BFonc201634_CR94","first-page":"5767","volume":"60","author":"RF Souza","year":"2000","unstructured":"Souza RF, Shewmake K, Beer DG, Cryer B, Spechler SJ . Selective inhibition of cyclooxygenase-2 suppresses growth and induces apoptosis in human esophageal adenocarcinoma cells. Cancer Res 2000; 60: 5767\u20135772.","journal-title":"Cancer Res"},{"key":"BFonc201634_CR95","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1053\/gast.2002.32371","volume":"122","author":"NS Buttar","year":"2002","unstructured":"Buttar NS, Wang KK, Leontovich O, Westcott JY, Pacifico RJ, Anderson MA et al. Chemoprevention of esophageal adenocarcinoma by COX-2 inhibitors in an animal model of Barrett\u2019s esophagus. Gastroenterology 2002; 122: 1101\u20131112.","journal-title":"Gastroenterology"},{"key":"BFonc201634_CR96","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/S1542-3565(04)00389-1","volume":"2","author":"M Bardou","year":"2004","unstructured":"Bardou M, Barkun A, Ghosn J, Hudson M, Rahme E . Effect of chronic intake of NSAIDs and cyclooxygenase 2\u2014selective inhibitors on esophageal cancer incidence. Clin Gastroenterol Hepatol 2004; 2: 880\u2013887.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"BFonc201634_CR97","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/nrc2734","volume":"9","author":"H Yu","year":"2009","unstructured":"Yu H, Pardoll D, Jove R . STATs in cancer inflammation and immunity: a leading role for STAT3. Nat Rev Cancer 2009; 9: 798\u2013809.","journal-title":"Nat Rev Cancer"},{"key":"BFonc201634_CR98","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1158\/1078-0432.CCR-13-1664","volume":"20","author":"J Gong","year":"2014","unstructured":"Gong J, Xie J, Bedolla R, Rivas P, Chakravarthy D, Freeman JW et al. Combined targeting of STAT3\/NF-\u03baB\/COX-2\/EP4 for effective management of pancreatic cancer. Clin Cancer Res 2014; 20: 1259\u20131273.","journal-title":"Clin Cancer Res"},{"key":"BFonc201634_CR99","doi-asserted-by":"crossref","first-page":"e24117","DOI":"10.4161\/onci.24117","volume":"2","author":"TJ Waldron","year":"2013","unstructured":"Waldron TJ, Quatromoni JG, Karakasheva TA, Singhal S, Rustgi AK . Myeloid derived suppressor cells: targets for therapy. Oncoimmunology 2013; 2: e24117.","journal-title":"Oncoimmunology"},{"key":"BFonc201634_CR100","doi-asserted-by":"crossref","first-page":"4499","DOI":"10.4049\/jimmunol.0802740","volume":"182","author":"S Ostrand-Rosenberg","year":"2009","unstructured":"Ostrand-Rosenberg S, Sinha P . Myeloid-derived suppressor cells: linking inflammation and cancer. J Immunol 2009; 182: 4499\u20134506.","journal-title":"J Immunol"},{"key":"BFonc201634_CR101","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/nri2506","volume":"9","author":"DI Gabrilovich","year":"2009","unstructured":"Gabrilovich DI, Nagaraj S . Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol 2009; 9: 162\u2013174.","journal-title":"Nat Rev Immunol"},{"key":"BFonc201634_CR102","doi-asserted-by":"crossref","first-page":"5365","DOI":"10.4049\/jimmunol.1103553","volume":"188","author":"P Jayaraman","year":"2012","unstructured":"Jayaraman P, Parikh F, Lopez-Rivera E, Hailemichael Y, Clark A, Ma G et al. Tumor-expressed inducible nitric oxide synthase controls induction of functional myeloid-derived suppressor cells through modulation of vascular endothelial growth factor release. J Immunol 2012; 188: 5365\u20135376.","journal-title":"J Immunol"},{"key":"BFonc201634_CR103","doi-asserted-by":"crossref","first-page":"689","DOI":"10.4049\/jimmunol.168.2.689","volume":"168","author":"A Mazzoni","year":"2002","unstructured":"Mazzoni A, Bronte V, Visintin A, Spitzer JH, Apolloni E, Serafini P et al. Myeloid suppressor lines inhibit T cell responses by an NO-dependent mechanism. J Immunol 2002; 168: 689\u2013695.","journal-title":"J Immunol"},{"key":"BFonc201634_CR104","doi-asserted-by":"crossref","first-page":"4336","DOI":"10.1182\/blood-2006-09-046201","volume":"109","author":"C Liu","year":"2007","unstructured":"Liu C, Yu S, Kappes J, Wang J, Grizzle WE, Zinn KR et al. Expansion of spleen myeloid suppressor cells represses NK cell cytotoxicity in tumor-bearing host. Blood 2007; 109: 4336\u20134342.","journal-title":"Blood"},{"key":"BFonc201634_CR105","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1158\/0008-5472.CAN-09-2587","volume":"70","author":"MK Srivastava","year":"2010","unstructured":"Srivastava MK, Sinha P, Clements VK, Rodriguez P, Ostrand-Rosenberg S . Myeloid-derived suppressor cells inhibit T-cell activation by depleting cystine and cysteine. Cancer Res 2010; 70: 68\u201377.","journal-title":"Cancer Res"},{"key":"BFonc201634_CR106","doi-asserted-by":"crossref","first-page":"5439","DOI":"10.1158\/0008-5472.CAN-07-6621","volume":"68","author":"P Serafini","year":"2008","unstructured":"Serafini P, Mgebroff S, Noonan K, Borrello I . Myeloid-derived suppressor cells promote cross-tolerance in B-cell lymphoma by expanding regulatory T cells. Cancer Res 2008; 68: 5439\u20135449.","journal-title":"Cancer Res"},{"key":"BFonc201634_CR107","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1038\/nm.3394","volume":"19","author":"DF Quail","year":"2013","unstructured":"Quail DF, Joyce JA . Microenvironmental regulation of tumor progression and metastasis. Nat Med 2013; 19: 1423\u20131437.","journal-title":"Nat Med"},{"key":"BFonc201634_CR108","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1007\/s00262-011-1028-0","volume":"60","author":"RF Gabitass","year":"2011","unstructured":"Gabitass RF, Annels NE, Stocken DD, Pandha HA, Middleton GW . Elevated myeloid-derived suppressor cells in pancreatic, esophageal and gastric cancer are an independent prognostic factor and are associated with significant elevation of the Th2 cytokine interleukin-13. Cancer Immunol Immunother 2011; 60: 1419\u20131430.","journal-title":"Cancer Immunol Immunother"},{"key":"BFonc201634_CR109","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1056\/NEJMoa1506348","volume":"373","author":"HM Lokhorst","year":"2015","unstructured":"Lokhorst HM, Plesner T, Laubach JP, Nahi H, Gimsing P, Hansson M et al. Targeting CD38 with daratumumab monotherapy in multiple myeloma. N Engl J Med 2015; 373: 1207\u20131219.","journal-title":"N Engl J Med"},{"key":"BFonc201634_CR110","doi-asserted-by":"crossref","first-page":"209","DOI":"10.4110\/in.2009.9.6.209","volume":"9","author":"T-Y Ha","year":"2009","unstructured":"Ha T-Y . The role of regulatory T cells in cancer. Immune Netw 2009; 9: 209\u2013235.","journal-title":"Immune Netw"},{"key":"BFonc201634_CR111","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/nrd3683","volume":"12","author":"H von Boehmer","year":"2013","unstructured":"von Boehmer H, Daniel C . Therapeutic opportunities for manipulating T(Reg) cells in autoimmunity and cancer. Nat Rev Drug Discov 2013; 12: 51\u201363.","journal-title":"Nat Rev Drug Discov"},{"key":"BFonc201634_CR112","first-page":"4404","volume":"9","author":"F Ichihara","year":"2003","unstructured":"Ichihara F, Kono K, Takahashi A, Kawaida H, Sugai H, Fujii H . Increased populations of regulatory T cells in peripheral blood and tumor-infiltrating lymphocytes in patients with gastric and esophageal cancers. Clin Cancer Res 2003; 9: 4404\u20134408.","journal-title":"Clin Cancer Res"},{"key":"BFonc201634_CR113","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1007\/s00262-005-0092-8","volume":"55","author":"K Kono","year":"2006","unstructured":"Kono K, Kawaida H, Takahashi A, Sugai H, Mimura K, Miyagawa N et al. CD4(+)CD25high regulatory T cells increase with tumor stage in patients with gastric and esophageal cancers. Cancer Immunol Immunother 2006; 55: 1064\u20131071.","journal-title":"Cancer Immunol Immunother"},{"key":"BFonc201634_CR114","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1038\/nm1093","volume":"10","author":"TJ Curiel","year":"2004","unstructured":"Curiel TJ, Coukos G, Zou L, Alvarez X, Cheng P, Mottram P et al. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med 2004; 10: 942\u2013949.","journal-title":"Nat Med"},{"key":"BFonc201634_CR115","first-page":"2941","volume":"35","author":"B Nabeki","year":"2015","unstructured":"Nabeki B, Ishigami S, Uchikado Y, Sasaki K, Kita Y, Okumura H et al. Interleukin-32 expression and Treg infiltration in esophageal squamous cell carcinoma. Anticancer Res 2015; 35: 2941\u20132947.","journal-title":"Anticancer Res"},{"key":"BFonc201634_CR116","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1177\/0300060513488504","volume":"41","author":"M Xia","year":"2013","unstructured":"Xia M, Zhao MQ, Wu K, Lin XY, Liu Y, Qin YJ . Investigations on the clinical significance of FOXP3 protein expression in cervical oesophageal cancer and the number of FOXP3+ tumour-infiltrating lymphocytes. J Int Med Res 2013; 41: 1002\u20131008.","journal-title":"J Int Med Res"},{"key":"BFonc201634_CR117","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1442-2050.2008.00855.x","volume":"22","author":"T Osaki","year":"2009","unstructured":"Osaki T, Saito H, Fukumoto Y, Yamada Y, Fukuda K, Tatebe S et al. Inverse correlation between NKG2D expression on CD8+ T cells and the frequency of CD4+CD25+ regulatory T cells in patients with esophageal cancer. Dis Esophagus 2009; 22: 49\u201354.","journal-title":"Dis Esophagus"},{"key":"BFonc201634_CR118","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s12013-011-9197-1","volume":"61","author":"T Xu","year":"2011","unstructured":"Xu T, Duan Q, Wang G, Hu B . CD4+CD25high regulatory T cell numbers and FOXP3 mRNA expression in patients with advanced esophageal cancer before and after chemotherapy. Cell Biochem Biophys 2011; 61: 389\u2013392.","journal-title":"Cell Biochem Biophys"},{"key":"BFonc201634_CR119","doi-asserted-by":"crossref","first-page":"20840","DOI":"10.18632\/oncotarget.4428","volume":"6","author":"E Vacchelli","year":"2015","unstructured":"Vacchelli E, Semeraro M, Enot DP, Chaba K, Poirier Colame V, Dartigues P et al. Negative prognostic impact of regulatory T cell infiltration in surgically resected esophageal cancer post-radiochemotherapy. Oncotarget 2015; 6: 20840\u201320850.","journal-title":"Oncotarget"},{"key":"BFonc201634_CR120","doi-asserted-by":"crossref","first-page":"276","DOI":"10.3389\/fimmu.2014.00276","volume":"5","author":"SR Bailey","year":"2014","unstructured":"Bailey SR, Nelson MH, Himes RA, Li Z, Mehrotra S, Paulos CM . Th17 cells in cancer: the ultimate identity crisis. Front Immunol 2014; 5: 276.","journal-title":"Front Immunol"},{"key":"BFonc201634_CR121","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nri2742","volume":"10","author":"W Zou","year":"2010","unstructured":"Zou W, Restifo NP . TH17 cells in tumour immunity and immunotherapy. Nat Rev Immunol 2010; 10: 248\u2013256.","journal-title":"Nat Rev Immunol"},{"key":"BFonc201634_CR122","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.immuni.2011.12.019","volume":"36","author":"F Chalmin","year":"2012","unstructured":"Chalmin F, Mignot G, Bruchard M, Chevriaux A, V\u00e9gran F, Hichami A et al. Stat3 and Gfi-1 transcription factors control Th17 cell immunosuppressive activity via the regulation of ectonucleotidase expression. Immunity 2012; 36: 362\u2013373.","journal-title":"Immunity"},{"key":"BFonc201634_CR123","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1084\/jem.20131459","volume":"211","author":"J Gomez-Rodriguez","year":"2014","unstructured":"Gomez-Rodriguez J, Wohlfert EA, Handon R, Meylan F, Wu JZ, Anderson SM et al. Itk-mediated integration of T cell receptor and cytokine signaling regulates the balance between Th17 and regulatory T cells. J Exp Med 2014; 211: 529\u2013543.","journal-title":"J Exp Med"},{"key":"BFonc201634_CR124","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.cellimm.2011.10.015","volume":"272","author":"D Chen","year":"2012","unstructured":"Chen D, Hu Q, Mao C, Jiao Z, Wang S, Yu L et al. Increased IL-17-producing CD4(+) T cells in patients with esophageal cancer. Cell Immunol 2012; 272: 166\u2013174.","journal-title":"Cell Immunol"},{"key":"BFonc201634_CR125","doi-asserted-by":"crossref","first-page":"5454","DOI":"10.3748\/wjg.v18.i38.5454","volume":"18","author":"ZJ Jiao","year":"2012","unstructured":"Jiao ZJ, Gao JJ, Hua SH, Chen DY, Wang WH, Wang H et al. Correlation between circulating myeloid-derived suppressor cells and Th17 cells in esophageal cancer. World J Gastroenterol 2012; 18: 5454\u20135461.","journal-title":"World J Gastroenterol"},{"key":"BFonc201634_CR126","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1158\/2326-6066.CIR-15-0046","volume":"3","author":"S Derks","year":"2015","unstructured":"Derks S, Nason KS, Liao X, Stachler MD, Liu KX, Liu JB et al. Epithelial PD-L2 expression marks Barrett\u2019s esophagus and esophageal adenocarcinoma. Cancer Immunol Res 2015; 3: 1123\u20131129.","journal-title":"Cancer Immunol Res"},{"key":"BFonc201634_CR127","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1084\/jem.192.7.1027","volume":"192","author":"GJ Freeman","year":"2000","unstructured":"Freeman GJ, Long AJ, Iwai Y, Bourque K, Chernova T, Nishimura H et al. Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J Exp Med 2000; 192: 1027\u20131034.","journal-title":"J Exp Med"},{"key":"BFonc201634_CR128","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.4049\/jimmunol.1401572","volume":"193","author":"S Ostrand-Rosenberg","year":"2014","unstructured":"Ostrand-Rosenberg S, Horn LA, Haile ST . The programmed death-1 immune-suppressive pathway: barrier to antitumor immunity. J Immunol 2014; 193: 3835\u20133841.","journal-title":"J Immunol"},{"key":"BFonc201634_CR129","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1158\/1078-0432.CCR-04-1469","volume":"11","author":"Y Ohigashi","year":"2005","unstructured":"Ohigashi Y, Sho M, Yamada Y, Tsurui Y, Hamada K, Ikeda N et al. Clinical significance of programmed death-1 ligand-1 and programmed death-1 ligand-2 expression in human esophageal cancer. Clin Cancer Res 2005; 11: 2947\u20132953.","journal-title":"Clin Cancer Res"},{"key":"BFonc201634_CR130","first-page":"6015","volume":"7","author":"L Chen","year":"2014","unstructured":"Chen L, Deng H, Lu M, Xu B, Wang Q, Jiang J et al. B7-H1 expression associates with tumor invasion and predicts patient\u2019s survival in human esophageal cancer. Int J Clin Exp Pathol 2014; 7: 6015\u20136023.","journal-title":"Int J Clin Exp Pathol"},{"key":"BFonc201634_CR131","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1056\/NEJMoa1200690","volume":"366","author":"SL Topalian","year":"2012","unstructured":"Topalian SL, Hodi FS, Brahmer JR, Gettinger SN, Smith DC, McDermott DF et al. Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. N Engl J Med 2012; 366: 2443\u20132454.","journal-title":"N Engl J Med"},{"key":"BFonc201634_CR132","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1038\/ni.1937","volume":"11","author":"SK Biswas","year":"2010","unstructured":"Biswas SK, Mantovani A . Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. Nat Immunol 2010; 11: 889\u2013896.","journal-title":"Nat Immunol"},{"key":"BFonc201634_CR133","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/nature13490","volume":"513","author":"OR Colegio","year":"2014","unstructured":"Colegio OR, Chu N-Q, Szabo AL, Chu T, Rhebergen AM, Jairam V et al. Functional polarization of tumour-associated macrophages by tumour-derived lactic acid. Nature 2014; 513: 559\u2013563.","journal-title":"Nature"},{"key":"BFonc201634_CR134","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.cell.2006.01.007","volume":"124","author":"J Condeelis","year":"2006","unstructured":"Condeelis J, Pollard JW . Macrophages: obligate partners for tumor cell migration, invasion, and metastasis. Cell 2006; 124: 263\u2013266.","journal-title":"Cell"},{"key":"BFonc201634_CR135","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1245\/s10434-014-3537-5","volume":"21","author":"T Miyashita","year":"2014","unstructured":"Miyashita T, Tajima H, Shah FA, Oshima M, Makino I, Nakagawara H et al. Impact of inflammation-metaplasia-adenocarcinoma sequence and inflammatory microenvironment in esophageal carcinogenesis using surgical rat models. Ann Surg Oncol 2014; 21: 2012\u20132019.","journal-title":"Ann Surg Oncol"},{"key":"BFonc201634_CR136","doi-asserted-by":"crossref","first-page":"e104453","DOI":"10.1371\/journal.pone.0104453","volume":"9","author":"J Gao","year":"2014","unstructured":"Gao J, Wu Y, Su Z, Amoah Barnie P, Jiao Z, Bie Q et al. Infiltration of alternatively activated macrophages in cancer tissue is associated with MDSC and Th2 polarization in patients with esophageal cancer. PLoS One 2014; 9: e104453.","journal-title":"PLoS One"},{"key":"BFonc201634_CR137","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1111\/j.1572-0241.2004.30733.x","volume":"99","author":"N Koide","year":"2004","unstructured":"Koide N, Nishio A, Sato T, Sugiyama A, Miyagawa S . Significance of macrophage chemoattractant protein-1 expression and macrophage infiltration in squamous cell carcinoma of the esophagus. Am J Gastroenterol 2004; 99: 1667\u20131674.","journal-title":"Am J Gastroenterol"},{"key":"BFonc201634_CR138","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1111\/cas.12188","volume":"104","author":"M Shigeoka","year":"2013","unstructured":"Shigeoka M, Urakawa N, Nakamura T, Nishio M, Watajima T, Kuroda D et al. Tumor associated macrophage expressing CD204 is associated with tumor aggressiveness of esophageal squamous cell carcinoma. Cancer Sci 2013; 104: 1112\u20131119.","journal-title":"Cancer Sci"},{"key":"BFonc201634_CR139","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/nrc1877","volume":"6","author":"R Kalluri","year":"2006","unstructured":"Kalluri R, Zeisberg M . Fibroblasts in cancer. Nat Rev Cancer 2006; 6: 392\u2013401.","journal-title":"Nat Rev Cancer"},{"key":"BFonc201634_CR140","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1158\/2159-8290.CD-12-0206","volume":"2","author":"AK Mitra","year":"2012","unstructured":"Mitra AK, Zillhardt M, Hua Y, Tiwari P, Murmann AE, Peter ME et al. MicroRNAs reprogram normal fibroblasts into cancer-associated fibroblasts in ovarian cancer. Cancer Discov 2012; 2: 1100\u20131108.","journal-title":"Cancer Discov"},{"key":"BFonc201634_CR141","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1093\/carcin\/bgv067","volume":"36","author":"K Tanaka","year":"2015","unstructured":"Tanaka K, Miyata H, Sugimura K, Fukuda S, Kanemura T, Yamashita K et al. miR-27 is associated with chemoresistance in esophageal cancer through transformation of normal fibroblasts to cancer-associated fibroblasts. Carcinogenesis 2015; 36: 894\u2013903.","journal-title":"Carcinogenesis"},{"key":"BFonc201634_CR142","doi-asserted-by":"crossref","first-page":"2788","DOI":"10.1101\/gad.1544507","volume":"21","author":"T Okawa","year":"2007","unstructured":"Okawa T, Michaylira CZ, Kalabis J, Stairs DB, Nakagawa H, Andl CD et al. The functional interplay between EGFR overexpression, hTERT activation, and p53 mutation in esophageal epithelial cells with activation of stromal fibroblasts induces tumor development, invasion, and differentiation. Genes Dev 2007; 21: 2788\u20132803.","journal-title":"Genes Dev"},{"key":"BFonc201634_CR143","doi-asserted-by":"crossref","first-page":"11026","DOI":"10.1073\/pnas.0914295107","volume":"107","author":"KD Grugan","year":"2010","unstructured":"Grugan KD, Miller CG, Yao Y, Michaylira CZ, Ohashi S, Klein-Szanto AJ et al. Fibroblast-secreted hepatocyte growth factor plays a functional role in esophageal squamous cell carcinoma invasion. Proc Natl Acad Sci USA 2010; 107: 11026\u201311031.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc201634_CR144","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1053\/j.gastro.2008.02.061","volume":"134","author":"K Noma","year":"2008","unstructured":"Noma K, Smalley KSM, Lioni M, Naomoto Y, Tanaka N, El-Deiry W et al. The essential role of fibroblasts in esophageal squamous cell carcinoma-induced angiogenesis. Gastroenterology 2008; 134: 1981\u20131993.","journal-title":"Gastroenterology"},{"key":"BFonc201634_CR145","doi-asserted-by":"crossref","first-page":"4017","DOI":"10.1158\/1078-0432.CCR-08-2824","volume":"15","author":"C Zhang","year":"2009","unstructured":"Zhang C, Fu L, Fu J, Hu L, Yang H, Rong TH et al. Fibroblast growth factor receptor 2-positive fibroblasts provide a suitable microenvironment for tumor development and progression in esophageal carcinoma. Clin Cancer Res 2009; 15: 4017\u20134027.","journal-title":"Clin Cancer Res"},{"key":"BFonc201634_CR146","doi-asserted-by":"crossref","first-page":"e99955","DOI":"10.1371\/journal.pone.0099955","volume":"9","author":"SY Ha","year":"2014","unstructured":"Ha SY, Yeo S-Y, Xuan Y, Kim S-H . The prognostic significance of cancer-associated fibroblasts in esophageal squamous cell carcinoma. PLoS One 2014; 9: e99955.","journal-title":"PLoS One"},{"key":"BFonc201634_CR147","doi-asserted-by":"crossref","first-page":"7275","DOI":"10.1007\/s13277-014-1987-9","volume":"35","author":"Y Chen","year":"2014","unstructured":"Chen Y, Li X, Yang H, Xia Y, Guo L, Wu X et al. Expression of basic fibroblast growth factor, CD31, and \u03b1-smooth muscle actin and esophageal cancer recurrence after definitive chemoradiation. Tumour Biol 2014; 35: 7275\u20137282.","journal-title":"Tumour Biol"},{"key":"BFonc201634_CR148","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.bbrc.2015.02.001","volume":"458","author":"C-H Bao","year":"2015","unstructured":"Bao C-H, Wang X-T, Ma W, Wang N-N, Un Nesa E, Wang J-B et al. Irradiated fibroblasts promote epithelial-mesenchymal transition and HDGF expression of esophageal squamous cell carcinoma. Biochem Biophys Res Commun 2015; 458: 441\u2013447.","journal-title":"Biochem Biophys Res Commun"},{"key":"BFonc201634_CR149","doi-asserted-by":"crossref","first-page":"A52","DOI":"10.1136\/gutjnl-2012-302514a.121","volume":"61","author":"AL Hayden","year":"2012","unstructured":"Hayden AL, Derouet MF, Noble F, Primrose JN, Blaydes JP, Thomas G et al. OC-121 fibroblast activation in the tumour microenvironment promotes tumour cell invasion and resistance to chemotherapy in oesophageal adenocarcinoma. Gut 2012; 61: A52\u2013A53.","journal-title":"Gut"},{"key":"BFonc201634_CR150","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1002\/path.4467","volume":"235","author":"TJ Underwood","year":"2015","unstructured":"Underwood TJ, Hayden AL, Derouet M, Garcia E, Noble F, White MJ et al. Cancer-associated fibroblasts predict poor outcome and promote periostin-dependent invasion in oesophageal adenocarcinoma. J Pathol 2015; 235: 466\u2013477.","journal-title":"J Pathol"},{"key":"BFonc201634_CR151","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/nrc1926","volume":"6","author":"B Bierie","year":"2006","unstructured":"Bierie B, Moses HL . Tumour microenvironment: TGFbeta: the molecular Jekyll and Hyde of cancer. Nat Rev Cancer 2006; 6: 506\u2013520.","journal-title":"Nat Rev Cancer"},{"key":"BFonc201634_CR152","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1038\/nrc3603","volume":"13","author":"M Pickup","year":"2013","unstructured":"Pickup M, Novitskiy S, Moses HL . The roles of TGF\u03b2 in the tumour microenvironment. Nat Rev Cancer 2013; 13: 788\u2013799.","journal-title":"Nat Rev Cancer"},{"key":"BFonc201634_CR153","first-page":"1241","volume":"20","author":"DA Lebman","year":"2002","unstructured":"Lebman DA, Edmiston JS, Chung TD, Snyder SR . Heterogeneity in the transforming growth factor beta response of esophageal cancer cells. Int J Oncol 2002; 20: 1241\u20131246.","journal-title":"Int J Oncol"},{"key":"BFonc201634_CR154","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1136\/gut.2005.076430","volume":"55","author":"BA Onwuegbusi","year":"2006","unstructured":"Onwuegbusi BA, Aitchison A, Chin S-F, Kranjac T, Mills I, Huang Y et al. Impaired transforming growth factor beta signalling in Barrett\u2019s carcinogenesis due to frequent SMAD4 inactivation. Gut 2006; 55: 764\u2013774.","journal-title":"Gut"},{"key":"BFonc201634_CR155","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1002\/cncr.10727","volume":"95","author":"M Fukuchi","year":"2002","unstructured":"Fukuchi M, Masuda N, Miyazaki T, Nakajima M, Osawa H, Kato H et al. Decreased Smad4 expression in the transforming growth factor-beta signaling pathway during progression of esophageal squamous cell carcinoma. Cancer 2002; 95: 737\u2013743.","journal-title":"Cancer"},{"key":"BFonc201634_CR156","doi-asserted-by":"crossref","first-page":"e95509","DOI":"10.1371\/journal.pone.0095509","volume":"9","author":"L Wu","year":"2014","unstructured":"Wu L, Herman JG, Brock M V, Wu K, Mao G, Yan W et al. Silencing DACH1 promotes esophageal cancer growth by inhibiting TGF-\u03b2 signaling. PLoS One 2014; 9: e95509.","journal-title":"PLoS One"},{"key":"BFonc201634_CR157","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1158\/1940-6207.CAPR-12-0352","volume":"6","author":"J Hou","year":"2013","unstructured":"Hou J, Liao L-D, Xie Y-M, Zeng F-M, Ji X, Chen B et al. DACT2 is a candidate tumor suppressor and prognostic marker in esophageal squamous cell carcinoma. Cancer Prev Res (Phila) 2013; 6: 791\u2013800.","journal-title":"Cancer Prev Res (Phila)"},{"key":"BFonc201634_CR158","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/ijc.10929","volume":"104","author":"Y Fukai","year":"2003","unstructured":"Fukai Y, Fukuchi M, Masuda N, Osawa H, Kato H, Nakajima T et al. Reduced expression of transforming growth factor-beta receptors is an unfavorable prognostic factor in human esophageal squamous cell carcinoma. Int J Cancer 2003; 104: 161\u2013166.","journal-title":"Int J Cancer"},{"key":"BFonc201634_CR159","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1158\/0008-5472.CAN-12-1962","volume":"73","author":"S Song","year":"2013","unstructured":"Song S, Maru DM, Ajani JA, Chan C-H, Honjo S, Lin H-K et al. Loss of TGF-\u03b2 adaptor \u03b22SP activates notch signaling and SOX9 expression in esophageal adenocarcinoma. Cancer Res 2013; 73: 2159\u20132169.","journal-title":"Cancer Res"},{"key":"BFonc201634_CR160","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1002\/mc.20259","volume":"45","author":"BHA von Rahden","year":"2006","unstructured":"von Rahden BHA, Stein HJ, Feith M, P\u00fchringer F, Theisen J, Siewert JR et al. Overexpression of TGF-beta1 in esophageal (Barrett\u2019s) adenocarcinoma is associated with advanced stage of disease and poor prognosis. Mol Carcinog 2006; 45: 786\u2013794.","journal-title":"Mol Carcinog"},{"key":"BFonc201634_CR161","first-page":"1593","volume":"23","author":"AH Kim","year":"2003","unstructured":"Kim AH, Lebman DA, Dietz CM, Snyder SR, Eley KW, Chung TD . Transforming growth factor-\u03b2 is an endogenous radioresistance factor in the esophageal adenocarcinoma cell line OE-33. Int J Oncol 2003; 23: 1593\u20131599.","journal-title":"Int J Oncol"},{"key":"BFonc201634_CR162","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/nrm1261","volume":"4","author":"C Birchmeier","year":"2003","unstructured":"Birchmeier C, Birchmeier W, Gherardi E, Vande Woude GF . Met, metastasis, motility and more. Nat Rev Mol Cell Biol 2003; 4: 915\u2013925.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"BFonc201634_CR163","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s12885-015-1120-5","volume":"15","author":"L Dreikhausen","year":"2015","unstructured":"Dreikhausen L, Blank S, Sisic L, Heger U, Weichert W, J\u00e4ger D et al. Association of angiogenic factors with prognosis in esophageal cancer. BMC Cancer 2015; 15: 121.","journal-title":"BMC Cancer"},{"key":"BFonc201634_CR164","doi-asserted-by":"crossref","first-page":"6190","DOI":"10.1158\/1078-0432.CCR-04-2553","volume":"11","author":"Y Ren","year":"2005","unstructured":"Ren Y, Cao B, Law S, Xie Y, Lee PY, Cheung L et al. Hepatocyte growth factor promotes cancer cell migration and angiogenic factors expression: a prognostic marker of human esophageal squamous cell carcinomas. Clin Cancer Res 2005; 11: 6190\u20136197.","journal-title":"Clin Cancer Res"},{"key":"BFonc201634_CR165","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0304-3835(95)03967-2","volume":"97","author":"N Takada","year":"1995","unstructured":"Takada N, Yano Y, Matsuda T, Otani S, Osugi H, Higashino M et al. Expression of immunoreactive human hepatocyte growth factor in human esophageal squamous cell carcinomas. Cancer Lett 1995; 97: 145\u2013148.","journal-title":"Cancer Lett"},{"key":"BFonc201634_CR166","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1038\/sj.bjc.6604251","volume":"98","author":"JB Tuynman","year":"2008","unstructured":"Tuynman JB, Lagarde SM, Ten Kate FJW, Richel DJ, van Lanschot JJB . Met expression is an independent prognostic risk factor in patients with oesophageal adenocarcinoma. Br J Cancer 2008; 98: 1102\u20131108.","journal-title":"Br J Cancer"},{"key":"BFonc201634_CR167","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1667\/RR2790.1","volume":"177","author":"ZS Patel","year":"2012","unstructured":"Patel ZS, Grugan KD, Rustgi AK, Cucinotta FA, Huff JL . Ionizing radiation enhances esophageal epithelial cell migration and invasion through a paracrine mechanism involving stromal-derived hepatocyte growth factor. Radiat Res 2012; 177: 200\u2013208.","journal-title":"Radiat Res"},{"key":"BFonc201634_CR168","doi-asserted-by":"crossref","first-page":"401","DOI":"10.3892\/ol.2013.1409","volume":"6","author":"Z Xu","year":"2013","unstructured":"Xu Z, Wang S, Wu M, Zeng W, Wang X, Dong Z . TGF\u03b21 and HGF protein secretion by esophageal squamous epithelial cells and stromal fibroblasts in oesophageal carcinogenesis. Oncol Lett 2013; 6: 401\u2013406.","journal-title":"Oncol Lett"},{"key":"BFonc201634_CR169","doi-asserted-by":"crossref","first-page":"5936","DOI":"10.1158\/1078-0432.CCR-06-1208","volume":"12","author":"MR Anderson","year":"2006","unstructured":"Anderson MR, Harrison R, Atherfold PA, Campbell MJ, Darnton SJ, Obszynska J et al. Met receptor signaling: a key effector in esophageal adenocarcinoma. Clin Cancer Res 2006; 12: 5936\u20135943.","journal-title":"Clin Cancer Res"},{"key":"BFonc201634_CR170","first-page":"315","volume":"11","author":"Y Kitadai","year":"2004","unstructured":"Kitadai Y, Onogawa S, Kuwai T, Matsumura S, Hamada H, Ito M et al. Angiogenic switch occurs during the precancerous stage of human esophageal squamous cell carcinoma. Oncol Rep 2004; 11: 315\u2013319.","journal-title":"Oncol Rep"},{"key":"BFonc201634_CR171","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/1096-9896(2000)9999:9999<::AID-PATH709>3.0.CO;2-F","volume":"192","author":"A Couvelard","year":"2000","unstructured":"Couvelard A, Paraf F, Gratio V, Scoazec JY, H\u00e9nin D, Degott C et al. Angiogenesis in the neoplastic sequence of Barrett\u2019s oesophagus. Correlation with VEGF expression. J Pathol 2000; 192: 14\u201318.","journal-title":"J Pathol"},{"key":"BFonc201634_CR172","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1038\/nrc3627","volume":"13","author":"HL Goel","year":"2013","unstructured":"Goel HL, Mercurio AM . VEGF targets the tumour cell. Nat Rev Cancer 2013; 13: 871\u2013882.","journal-title":"Nat Rev Cancer"},{"key":"BFonc201634_CR173","doi-asserted-by":"crossref","first-page":"7194","DOI":"10.1038\/sj.onc.1210535","volume":"26","author":"T-K Ito","year":"2007","unstructured":"Ito T-K, Ishii G, Chiba H, Ochiai A . The VEGF angiogenic switch of fibroblasts is regulated by MMP-7 from cancer cells. Oncogene 2007; 26: 7194\u20137203.","journal-title":"Oncogene"},{"key":"BFonc201634_CR174","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1634\/theoncologist.12-10-1165","volume":"12","author":"S Ekman","year":"2007","unstructured":"Ekman S, Bergqvist M, Heldin C-H, Lennartsson J . Activation of growth factor receptors in esophageal cancer\u2014implications for therapy. Oncologist 2007; 12: 1165\u20131177.","journal-title":"Oncologist"},{"key":"BFonc201634_CR175","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1007\/s00268-006-0373-1","volume":"31","author":"C M\u00f6bius","year":"2007","unstructured":"M\u00f6bius C, Freire J, Becker I, Feith M, Br\u00fccher BLDM, Hennig M et al. VEGF-C expression in squamous cell carcinoma and adenocarcinoma of the esophagus. World J Surg 2007; 31: 1768\u20131772 discussion 1773\u20131774.","journal-title":"World J Surg"},{"key":"BFonc201634_CR176","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1158\/1055-9965.EPI-12-0020","volume":"21","author":"M Chen","year":"2012","unstructured":"Chen M, Cai E, Huang J, Yu P, Li K . Prognostic value of vascular endothelial growth factor expression in patients with esophageal cancer: a systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev 2012; 21: 1126\u20131134.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"BFonc201634_CR177","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s11670-004-0002-1","volume":"16","author":"W Xu","year":"2004","unstructured":"Xu W, Yang G, Zhou L, Xie Y, Zhang L . Prognostic value of VEGF expression in primary esophageal squamous cell carcinoma. Chinese J Cancer Res 2004; 16: 85\u201389.","journal-title":"Chinese J Cancer Res"},{"key":"BFonc201634_CR178","first-page":"83","volume":"4","author":"H Zhang","year":"2007","unstructured":"Zhang H, Zhang L, Chen K, Gao D, He F, Zhang Y . Expression of vascular endothelial growth factor C and its clinical significance in human esophageal squamous cell carcinoma. Cancer Biol Med 2007; 4: 83\u201388.","journal-title":"Cancer Biol Med"},{"key":"BFonc201634_CR179","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1067\/mtc.2003.203","volume":"125","author":"RVN Lord","year":"2003","unstructured":"Lord RVN, Park JM, Wickramasinghe K, DeMeester SR, Oberg S, Salonga D et al. Vascular endothelial growth factor and basic fibroblast growth factor expression in esophageal adenocarcinoma and Barrett esophagus. J Thorac Cardiovasc Surg 2003; 125: 246\u2013253.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"BFonc201634_CR180","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1007\/s11605-011-1814-1","volume":"16","author":"MJD Prins","year":"2012","unstructured":"Prins MJD, Verhage RJJ, ten Kate FJW, van Hillegersberg R . Cyclooxygenase isoenzyme-2 and vascular endothelial growth factor are associated with poor prognosis in esophageal adenocarcinoma. J Gastrointest Surg 2012; 16: 956\u2013966.","journal-title":"J Gastrointest Surg"},{"key":"BFonc201634_CR181","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s10555-010-9256-x","volume":"29","author":"X Sun","year":"2010","unstructured":"Sun X, Cheng G, Hao M, Zheng J, Zhou X, Zhang J et al. CXCL12 \/ CXCR4 \/ CXCR7 chemokine axis and cancer progression. Cancer Metastasis Rev 2010; 29: 709\u2013722.","journal-title":"Cancer Metastasis Rev"},{"key":"BFonc201634_CR182","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1093\/jnci\/dji431","volume":"97","author":"JT Kaifi","year":"2005","unstructured":"Kaifi JT, Yekebas EF, Schurr P, Obonyo D, Wachowiak R, Busch P et al. Tumor-cell homing to lymph nodes and bone marrow and CXCR4 expression in esophageal cancer. J Natl Cancer Inst 2005; 97: 1840\u20131847.","journal-title":"J Natl Cancer Inst"},{"key":"BFonc201634_CR183","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1186\/1479-5876-11-238","volume":"11","author":"M Tachezy","year":"2013","unstructured":"Tachezy M, Zander H, Gebauer F, von Loga K, Pantel K, Izbicki JR et al. CXCR7 expression in esophageal cancer. J Transl Med 2013; 11: 238.","journal-title":"J Transl Med"},{"key":"BFonc201634_CR184","first-page":"65","volume":"21","author":"K Sasaki","year":"2009","unstructured":"Sasaki K, Natsugoe S, Ishigami S, Matsumoto M, Okumura H, Setoyama T et al. Expression of CXCL12 and its receptor CXCR4 in esophageal squamous cell carcinoma. Oncol Rep 2009; 21: 65\u201371.","journal-title":"Oncol Rep"},{"key":"BFonc201634_CR185","first-page":"154","volume":"28","author":"D-F Wang","year":"2009","unstructured":"Wang D-F, Lou N, Zeng C-G, Zhang X, Chen F-J . Expression of CXCL12\/CXCR4 and its correlation to prognosis in esophageal squamous cell carcinoma. Ai Zheng 2009; 28: 154\u2013158.","journal-title":"Ai Zheng"},{"key":"BFonc201634_CR186","first-page":"711","volume":"26","author":"SJ Gros","year":"2012","unstructured":"Gros SJ, Graeff H, Drenckhan A, Kurschat N, Blessmann M, Rawnaq T et al. CXCR4\/SDF-1\u03b1-mediated chemotaxis in an in vivo model of metastatic esophageal carcinoma. In Vivo 2012; 26: 711\u2013718.","journal-title":"In Vivo"},{"key":"BFonc201634_CR187","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/1746-1596-8-104","volume":"8","author":"T Wang","year":"2013","unstructured":"Wang T, Mi Y, Pian L, Gao P, Xu H, Zheng Y et al. RNAi targeting CXCR4 inhibits proliferation and invasion of esophageal carcinoma cells. Diagn Pathol 2013; 8: 104.","journal-title":"Diagn Pathol"},{"key":"BFonc201634_CR188","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/nrm3904","volume":"15","author":"C Bonnans","year":"2014","unstructured":"Bonnans C, Chou J, Werb Z . Remodelling the extracellular matrix in development and disease. Nat Rev Mol Cell Biol 2014; 15: 786\u2013801.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"BFonc201634_CR189","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1242\/dmm.004077","volume":"4","author":"TR Cox","year":"2011","unstructured":"Cox TR, Erler JT . Remodeling and homeostasis of the extracellular matrix: implications for fibrotic diseases and cancer. Dis Model Mech 2011; 4: 165\u2013178.","journal-title":"Dis Model Mech"},{"key":"BFonc201634_CR190","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.cell.2010.03.015","volume":"141","author":"K Kessenbrock","year":"2010","unstructured":"Kessenbrock K, Plaks V, Werb Z . Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 2010; 141: 52\u201367.","journal-title":"Cell"},{"key":"BFonc201634_CR191","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1002\/gcc.20444","volume":"46","author":"SFT Fong","year":"2007","unstructured":"Fong SFT, Dietzsch E, Fong KSK, Hollosi P, Asuncion L, He Q et al. Lysyl oxidase-like 2 expression is increased in colon and esophageal tumors and associated with less differentiated colon tumors. Genes Chromosomes Cancer 2007; 46: 644\u2013655.","journal-title":"Genes Chromosomes Cancer"},{"key":"BFonc201634_CR192","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.3892\/or.2014.3095","volume":"31","author":"Y Zhang","year":"2014","unstructured":"Zhang Y, Wang Q, Ma A, Li Y, Li R, Wang Y . Functional expression of TLR9 in esophageal cancer. Oncol Rep 2014; 31: 2298\u20132304.","journal-title":"Oncol Rep"},{"key":"BFonc201634_CR193","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1111\/j.1572-0241.2005.50018.x","volume":"100","author":"Z-D Gu","year":"2005","unstructured":"Gu Z-D, Li J-Y, Li M, Gu J, Shi X-T, Ke Y et al. Matrix metalloproteinases expression correlates with survival in patients with esophageal squamous cell carcinoma. Am J Gastroenterol 2005; 100: 1835\u20131843.","journal-title":"Am J Gastroenterol"},{"key":"BFonc201634_CR194","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1054\/bjoc.2001.1929","volume":"85","author":"MT Salmela","year":"2001","unstructured":"Salmela MT, Karjalainen-Lindsberg ML, Puolakkainen P, Saarialho-Kere U . Upregulation and differential expression of matrilysin (MMP-7) and metalloelastase (MMP-12) and their inhibitors TIMP-1 and TIMP-3 in Barrett\u2019s oesophageal adenocarcinoma. Br J Cancer 2001; 85: 383\u2013392.","journal-title":"Br J Cancer"},{"key":"BFonc201634_CR195","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/1479-5876-8-99","volume":"8","author":"M Grimm","year":"2010","unstructured":"Grimm M, Lazariotou M, Kircher S, Stuermer L, Reiber C, H\u00f6felmayr A et al. MMP-1 is a (pre-)invasive factor in Barrett-associated esophageal adenocarcinomas and is associated with positive lymph node status. J Transl Med 2010; 8: 99.","journal-title":"J Transl Med"},{"key":"BFonc201634_CR196","doi-asserted-by":"crossref","first-page":"897","DOI":"10.3390\/cancers6020897","volume":"6","author":"RL Carpenter","year":"2014","unstructured":"Carpenter RL, Lo H-W . STAT3 target genes relevant to human cancers. Cancers (Basel) 2014; 6: 897\u2013925.","journal-title":"Cancers (Basel)"},{"key":"BFonc201634_CR197","doi-asserted-by":"crossref","first-page":"e59","DOI":"10.1038\/oncsis.2013.17","volume":"2","author":"GS Wong","year":"2013","unstructured":"Wong GS, Lee J-S, Park Y-Y, Klein-Szanto A J, Waldron TJ, Cukierman E et al. Periostin cooperates with mutant p53 to mediate invasion through the induction of STAT1 signaling in the esophageal tumor microenvironment. Oncogenesis 2013; 2: e59.","journal-title":"Oncogenesis"},{"key":"BFonc201634_CR198","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/path.1846","volume":"207","author":"J Zhang","year":"2005","unstructured":"Zhang J, Zhi H, Zhou C, Ding F, Luo A, Zhang X et al. Up-regulation of fibronectin in oesophageal squamous cell carcinoma is associated with activation of the Erk pathway. J Pathol 2005; 207: 402\u2013409.","journal-title":"J Pathol"},{"key":"BFonc201634_CR199","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1158\/0008-5472.CAN-11-1351","volume":"72","author":"MA Thelin","year":"2012","unstructured":"Thelin MA, Svensson KJ, Shi X, Bagher M, Axelsson J, Isinger-Ekstrand A et al. Dermatan sulfate is involved in the tumorigenic properties of esophagus squamous cell carcinoma. Cancer Res 2012; 72: 1943\u20131952.","journal-title":"Cancer Res"},{"key":"BFonc201634_CR200","first-page":"1861","volume":"148","author":"C Wang","year":"1996","unstructured":"Wang C, Tammi M, Guo H, Tammi R . Hyaluronan distribution in the normal epithelium of esophagus, stomach, and colon and their cancers. Am J Pathol 1996; 148: 1861\u20131869.","journal-title":"Am J Pathol"},{"key":"BFonc201634_CR201","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1476-4598-10-30","volume":"10","author":"S Twarock","year":"2011","unstructured":"Twarock S, Freudenberger T, Poscher E, Dai G, Jannasch K, Dullin C et al. Inhibition of oesophageal squamous cell carcinoma progression by in vivo targeting of hyaluronan synthesis. Mol Cancer 2011; 10: 30.","journal-title":"Mol Cancer"},{"key":"BFonc201634_CR202","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3892\/ol.2013.1348","volume":"6","author":"J-X Huang","year":"2013","unstructured":"Huang J-X, Zhao K, Lin M, Wang Q, Xiao W, Lin M-S et al. HER2 gene amplification in esophageal squamous cell carcinoma is less than in gastroesophageal junction and gastric adenocarcinoma. Oncol Lett 2013; 6: 13\u201318.","journal-title":"Oncol Lett"},{"key":"BFonc201634_CR203","doi-asserted-by":"crossref","first-page":"3789","DOI":"10.1172\/JCI57100","volume":"121","author":"NR Bertos","year":"2011","unstructured":"Bertos NR, Park M . Breast cancer - one term, many entities? J Clin Invest 2011; 121: 3789\u20133796.","journal-title":"J Clin Invest"},{"key":"BFonc201634_CR204","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1126\/science.1232227","volume":"339","author":"LM Coussens","year":"2013","unstructured":"Coussens LM, Zitvogel L, Palucka AK . Neutralizing tumor-promoting chronic inflammation: a magic bullet? Science 2013; 339: 286\u2013291.","journal-title":"Science"},{"key":"BFonc201634_CR205","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1093\/jmcb\/mjs044","volume":"4","author":"X Cai","year":"2012","unstructured":"Cai X, Yin Y, Li N, Zhu D, Zhang J, Zhang C-Y et al. Re-polarization of tumor-associated macrophages to pro-inflammatory M1 macrophages by microRNA-155. J Mol Cell Biol 2012; 4: 341\u2013343.","journal-title":"J Mol Cell Biol"},{"key":"BFonc201634_CR206","first-page":"301ra130","volume":"7","author":"BR Seo","year":"2015","unstructured":"Seo BR, Bhardwaj P, Choi S, Gonzalez J, Andresen Eguiluz RC, Wang K et al. Obesity-dependent changes in interstitial ECM mechanics promote breast tumorigenesis. Sci Transl Med 2015; 7: 301ra130.","journal-title":"Sci Transl Med"},{"key":"BFonc201634_CR207","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nature12347","volume":"499","author":"S Yoshimoto","year":"2013","unstructured":"Yoshimoto S, Loo TM, Atarashi K, Kanda H, Sato S, Oyadomari S et al. Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome. Nature 2013; 499: 97\u2013101.","journal-title":"Nature"},{"key":"BFonc201634_CR208","first-page":"250ra115","volume":"6","author":"C-M Zhao","year":"2014","unstructured":"Zhao C-M, Hayakawa Y, Kodama Y, Muthupalani S, Westphalen CB, Andersen GT et al. Denervation suppresses gastric tumorigenesis. Sci Transl Med 2014; 6: 250ra115.","journal-title":"Sci Transl Med"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/onc201634.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc201634","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc201634.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T20:20:55Z","timestamp":1647894055000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/onc201634"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,29]]},"references-count":208,"journal-issue":{"issue":"41","published-print":{"date-parts":[[2016,10,13]]}},"alternative-id":["BFonc201634"],"URL":"https:\/\/doi.org\/10.1038\/onc.2016.34","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,29]]},"assertion":[{"value":"16 December 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 February 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}